Disease & disorder

SLC35A1-congenital disorder of glycosylation

MONDO:0011342

SLC35A1-CDG is an extremely rare form of CDG syndrome characterized clinically in the single reported case by repeated hemorrhagic incidents, including severe pulmonary hemorrhage.

Outbreak surveillance

Global reported events

Explore recent public health notices potentially related to SLC35A1-congenital disorder of glycosylation. Results are keyword matches, not yet verified disease-to-outbreak relationships.

View SLC35A1-congenital disorder of glycosylation on the outbreak map →
Clinical trials0
Recruiting0
Drug concepts studied0
Synonyms12
Advertisement
Background context

SLC35A1-CDG

SLC35A1-CDG is a rare inherited disorder that mainly affects the vascular systems of the body. It forms part of a large group of disorders called congenital disorders of glycosylation. It is caused by mutations in the SLC35A1 gene, located in the sixth chromosome.

Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Drugs being studied

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.